Michael Berry

Chief Tech/Sci/R&D Officer chez EVEREST MEDICINES LIMITED

Profil

Michael Berry is currently the Chief Technology Officer at Everest Medicines Ltd.
He previously worked as the Senior Director of Bioprocess Development at Portola Pharmaceuticals, Director at ARCA biopharma, Director of Manufacturing Sciences & Technology at Novartis Vaccines & Diagnostics SL, and Vice President at Dynavax Technologies Corp.
He is also the Chief Technical Operations Officer at Clover Biopharmaceuticals Ltd.
Berry received his undergraduate degree from De Montfort University, his graduate degree from The University of Manchester, and his doctorate from the University of Manitoba.

Postes actifs de Michael Berry

Sociétés	Poste	Début
EVEREST MEDICINES LIMITED	Chief Tech/Sci/R&D Officer	15/06/2023

Anciens postes connus de Michael Berry

Sociétés	Poste	Fin
DYNAVAX TECHNOLOGIES CORPORATION	Corporate Officer/Principal	01/08/2017
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/02/2015
Novartis Vaccines & Diagnostics SL	Corporate Officer/Principal	01/09/2013
ARCA BIOPHARMA, INC.	Director/Board Member	01/05/2009
CLOVER BIOPHARMACEUTICALS, LTD.	Chief Tech/Sci/R&D Officer	-

Formation de Michael Berry

The University of Manchester	Graduate Degree
University of Manitoba	Doctorate Degree
De Montfort University	Undergraduate Degree